Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis

Critical Care Medicine

Volumn 25, Issue 5, 1997, Pages 806-811

  Lugo, Gustavo ^a,b   Castañeda Hernández, Gilberto ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

Amikacin; Aminoglycosides; Correlation; Critically ill patients; Dosing; Hemodynamics; Multiple linear regression; Pharmacokinetics; Principal component analysis; Septic shock; Therapeutic drug monitoring; Vital support measures

Indexed keywords

ADRENALIN; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CATECHOLAMINE; CREATININE; DOPAMINE; NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CREATININE CLEARANCE; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG MONITORING; FEMALE; GRAM NEGATIVE SEPSIS; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MALE; MULTIPLE REGRESSION; POSITIVE END EXPIRATORY PRESSURE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL;

ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; APACHE; CRITICAL CARE; CROSS-SECTIONAL STUDIES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HALF-LIFE; HEMODYNAMIC PROCESSES; HUMANS; INFUSION PUMPS; INTENSIVE CARE UNITS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; SEPSIS;

EID: 0030977390     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199705000-00016     Document Type: Article

References (34)

1. Moore R, Smith C, Liethman P: Association of aminoglycoside plasma levels with therapeutic outcome in Gram negative pneumonia. Am J Med 1984; 77:652-657
2. Dasta JF, Armstrong DK: Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. Crit Care Med 1988; 16:327-330
3. Toll DA, Shikuma LR, Miller TQ, et al: Physiologic response of stress and aminoglycoside clearance in critically ill septic patients. Crit Care Med 1993; 21:248-251
4. Zaske DE: Aminoglycosides. In: Applied Pharmacokinetics. Evans WE, Shentag JJ, Jusko WJ (Eds). Spokane, WA, Applied Therapeutics, 1986, pp 331-381
5. Bone RC, Fisher CJ, Clemmer TP, et al (The Methylprednisolone Severe Sepsis Study Group): Sepsis syndrome: A valid clinical entity. Crit Care Med 1989; 17:389-393
6. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-830
7. Devine BJ: Gentamicin therapy. Drug Intelligence and Clinical Pharmacy 1974; 8:650-655
8. Sawchuk RJ, Zaske DE, Cipolle RJ, et al: Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther 1976; 21:362-367
9. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
10. Robert S, Zarowitz BJ, Peterson EL, et al: Predictability of creatinine clearance estimates in critically ill patients. Crit Care Med 1993; 21:1487-1495
11. Hocking RR: The analysis and selection of variables in linear regression. Biometrics 1976; 32:1-49
12. Sheiner LB, Beal SL: Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9:503-511
13. Peck CC, D'Argenio DZ, Rodman JH: Analysis of pharmacokinetic data for individual drug dosage regimens. In: Applied Pharmacokinetics. Evans WE, Shentag JJ, Jusko WJ (Eds). Spokane, WA, Applied Therapeutics, 1992, pp 1-16
14. Gyselynck AM, Forrey A, Cutler R: Pharmacokinetics of gentamicin: Distribution and plasma renal clearance. J Infect Dis 1971; 124(Suppl):S70-S76
15. Barza M: Predictability of blood levels of gentamicin in man. J Infect Dis 1975; 132:165-174
16. Kaye D: The unpredictability of serum concentrations of gentamicin: Pharmacokinetics of gentamicin in patients with normal and abnormal renal function. J Infect Dis 1974; 130:150-154
17. Hickling KG, Begg EJ, Perry RE, et al: Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Crit Care Med 1991; 19:1041-1047
18. Berry AJ: Respiratory support and renal function. Anesthesiology 1981; 55: 655-667
19. Richard C, Bendeux A, Delian F, et al: Effect of mechanical ventilation on hepatic drug pharmacokinetics. Chest 1986; 90:837-841
20. Perkins MW, Dasta JF, DeHaven B: The physiological implications of mechanical ventilation on pharmacokinetics. Drug Intelligence and Clinical Pharmacy 1989; 23:316-323
21. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
22. Dager EW: Aminoglycoside pharmacokinetics: Volume distribution in specific adult patient subgroups. Ann Pharmacother 1994; 28:944-951
23. Triginer C, Izquierdo Y, Fernández R, et al: Gentamicin volume distribution in critically ill patients. Intensive Care Med 1990; 16:303-306
24. Triginer C, Izquierdo Y, Fernández R, et al: Changes in gentamicin pharmacokinetics profiles induced by mechanical ventilation. Eur J Clin Pharmacol 1991; 40:297-302
25. Dorinsky PM, Gadek JE: Mechanisms of multiple non-pulmonary organ failure in ARDS. Chest 1989; 96:885-892
26. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock: Relation to multiple system organ failure and mortality. Chest 1993; 103:565-575
27. Marik PE: Aminoglycoside volume distribution and illness severity in critically ill septic patients. Anaesth Intensive Care 1993; 21:172-173
28. 2 extraction during progressive ischemia in canine skeletal muscle. J Appl Physiol 1995; 79:1351-1360
29. Moore RD, Lietman PS, Smith CR: Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987; 155:93-99
30. Marik PE, Lipman J, Scribate J, et al: A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients. J Antimicrob Agents Chemother 1991; 28:753-764
31. Zaske DE, Cipolle RJ, Strate RG: Gentamicin dosage requirements: Wide interpatient variations in 242 surgery patients with normal renal function. Surgery 1980; 87:164-169
32. Beckhouse MJ, Whyte IM, Byth PL, et al: Altered aminoglycoside pharmacokinetics in the critically ill. Anaesth Intensive Care 1988; 16:418-422
33. Hassan E, Ober J: Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients. Crit Care Med 1986; 14:394-398
34. Schumacher GE, Barr JT: Bayesian approach in pharmacokinetic decision making. Clin Pharm 1984; 3:525-529